Suppr超能文献

系统性肥大细胞增多症的胃肠道表现:多学科方法的必要性。

Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary Approach.

作者信息

Zanelli Magda, Pizzi Marco, Sanguedolce Francesca, Zizzo Maurizio, Palicelli Andrea, Soriano Alessandra, Bisagni Alessandra, Martino Giovanni, Caprera Cecilia, Moretti Marina, Masia Francesco, De Marco Loredana, Froio Elisabetta, Foroni Moira, Bernardelli Giuditta, Alvarez de Celis Maria Isabel, Giunta Alessandro, Merli Francesco, Ascani Stefano

机构信息

Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.

General Pathology and Cytopathology Unit, Department of Medicine-DMED, University of Padova, 35121 Padova, Italy.

出版信息

Cancers (Basel). 2021 Jul 1;13(13):3316. doi: 10.3390/cancers13133316.

Abstract

Mastocytosis represents a heterogeneous group of neoplastic mast cell disorders. The basic classification into a skin-limited disease and a systemic form with multi-organ involvement remains valid. Systemic mastocytosis is a disease often hard to diagnose, characterized by different symptoms originating from either the release of mast cell mediators or organ damage due to mast cell infiltration. Gastrointestinal symptoms represent one of the major causes of morbidity, being present in 60-80% of patients. A high index of suspicion by clinicians and pathologists is required to reach the diagnosis. Gastrointestinal mastocytosis can be a challenging diagnosis, as symptoms simulate other more common gastrointestinal diseases. The endoscopic appearance is generally unremarkable or nonspecific and gastrointestinal mast cell infiltration can be focal and subtle, requiring an adequate sampling with multiple biopsies by the endoscopists. Special stains, such as CD117, tryptase, and CD25, should be performed in order not to miss the gastrointestinal mast cell infiltrate. A proper patient's workup requires a multidisciplinary approach including gastroenterologists, endoscopists, hematologists, oncologists, and pathologists. The aim of this review is to analyze the clinicopathological features of gastrointestinal involvement in systemic mastocytosis, focusing on the relevance of a multidisciplinary approach.

摘要

肥大细胞增多症是一组异质性的肿瘤性肥大细胞疾病。将其基本分类为皮肤局限性疾病和累及多器官的系统性疾病仍然有效。系统性肥大细胞增多症是一种常常难以诊断的疾病,其特征是由肥大细胞介质释放或肥大细胞浸润导致的器官损伤所引起的不同症状。胃肠道症状是发病的主要原因之一,60% - 80%的患者存在该症状。临床医生和病理学家需要高度怀疑才能做出诊断。胃肠道肥大细胞增多症的诊断具有挑战性,因为其症状与其他更常见的胃肠道疾病相似。内镜表现通常不显著或无特异性,胃肠道肥大细胞浸润可能是局灶性且不明显的,这需要内镜医生进行多次活检以获取足够的样本。应进行特殊染色,如CD117、类胰蛋白酶和CD25染色,以免遗漏胃肠道肥大细胞浸润情况。对患者进行恰当的检查需要多学科方法,包括胃肠病学家、内镜医生、血液学家、肿瘤学家和病理学家。本综述的目的是分析系统性肥大细胞增多症胃肠道受累的临床病理特征,重点关注多学科方法的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c1/8269078/f7910b960144/cancers-13-03316-g001.jpg

相似文献

1
Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary Approach.
Cancers (Basel). 2021 Jul 1;13(13):3316. doi: 10.3390/cancers13133316.
2
Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Am J Surg Pathol. 2007 Nov;31(11):1669-76. doi: 10.1097/PAS.0b013e318078ce7a.
4
5
Gastrointestinal Mastocytosis: A Potential Diagnostic Pitfall to Be Aware.
Int J Surg Pathol. 2019 Sep;27(6):643-646. doi: 10.1177/1066896919846648. Epub 2019 May 2.
6
[Systemic mastocytosis].
Rev Prat. 2005 Oct 15;55(15):1629-36.
7
Systemic mastocytosis involving the gastrointestinal tract: clinicopathologic and molecular study of five cases.
Mod Pathol. 2008 Dec;21(12):1508-16. doi: 10.1038/modpathol.2008.158. Epub 2008 Oct 17.
8
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
Leuk Res. 2001 Jul;25(7):603-25. doi: 10.1016/s0145-2126(01)00038-8.
10
Clinicopathological characteristics of systemic mastocytosis in the intestine.
Histopathology. 2016 Dec;69(6):1021-1027. doi: 10.1111/his.13033. Epub 2016 Sep 16.

引用本文的文献

1
Unmasking systemic mastocytosis: a case of gastrointestinal involvement misdiagnosed as achalasia.
J Surg Case Rep. 2025 Aug 12;2025(8):rjaf590. doi: 10.1093/jscr/rjaf590. eCollection 2025 Aug.
2
Systemic mastocytosis: current status and challenges in 2024.
Blood Adv. 2025 May 13;9(9):2048-2062. doi: 10.1182/bloodadvances.2024012612.
3
Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms.
Front Allergy. 2024 Oct 18;5:1401187. doi: 10.3389/falgy.2024.1401187. eCollection 2024.
6
Asymptomatic Systemic Mastocytosis Uncovered During Routine Colonoscopy: A Case Report.
Cureus. 2024 May 14;16(5):e60286. doi: 10.7759/cureus.60286. eCollection 2024 May.
7
Aggressive systemic mastocytosis with multiple organ involvement: a case report.
Oxf Med Case Reports. 2023 Nov 28;2023(11):omad095. doi: 10.1093/omcr/omad095. eCollection 2023 Nov.
8
Small bowel obstruction: a rare presentation of systemic mastocytosis.
BMJ Case Rep. 2023 Sep 26;16(9):e255882. doi: 10.1136/bcr-2023-255882.
10
Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches.
JAAD Case Rep. 2023 Apr 28;36:63-66. doi: 10.1016/j.jdcr.2023.04.009. eCollection 2023 Jun.

本文引用的文献

1
Mast Cell Activation Disorders.
Medicina (Kaunas). 2021 Jan 30;57(2):124. doi: 10.3390/medicina57020124.
2
Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management.
Am J Hematol. 2021 Apr 1;96(4):508-525. doi: 10.1002/ajh.26118. Epub 2021 Feb 21.
4
Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.
Diagnostics (Basel). 2021 Jan 7;11(1):88. doi: 10.3390/diagnostics11010088.
5
Acute aleukemic mast cell leukemia: Report of a case and review of the literature.
Leuk Res Rep. 2020 Nov 26;14:100230. doi: 10.1016/j.lrr.2020.100230. eCollection 2020.
7
New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis.
Blood. 2020 Apr 16;135(16):1365-1376. doi: 10.1182/blood.2019000932.
9
Novel approaches to treating advanced systemic mastocytosis.
Clin Pharmacol. 2019 Jul 10;11:77-92. doi: 10.2147/CPAA.S206615. eCollection 2019.
10
ATP-Competitive Inhibitors Midostaurin and Avapritinib Have Distinct Resistance Profiles in Exon 17-Mutant KIT.
Cancer Res. 2019 Aug 15;79(16):4283-4292. doi: 10.1158/0008-5472.CAN-18-3139. Epub 2019 Jul 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验